Pharma Medica
Stephanie Stotz has worked as a Director of Medical Writing at Pharma Medica Research Inc. since August 2022. Prior to that, they were the Director of Scientific Development at Resverlogix Corp. from October 2018 to July 2022, and the Associate Director of Scientific Development from February 2017 to October 2018. Stephanie also has experience as a Research Associate at the University of Calgary from September 2013 to January 2017, and as a Postdoctoral fellow at Harvard University / Boston Children's Hospital from October 2003 to August 2013.
Stephanie Stotz completed their Bachelor of Science (B.Sc.) in Zoology/Animal Biology at the University of Calgary. Afterwards, they pursued their Master of Science (M.Sc.) in Neuroscience at the same institution. Stephanie then went on to earn their Doctor of Philosophy (Ph.D.) in Neuroscience, also from the University of Calgary.
Pharma Medica
Pharma Medica Research Inc is a full service contract research organization based in the greater Toronto area. We focus primarily on phase I, first-in-man, and bioequivalence trials in healthy volunteers, special populations, and patients. By remaining specialized in this area, we have developed true expertise in the field. Our track record speaks for itself we have completed over 1500 clinical trials, been successfully audited by the FDA and EMEA, and helped to bring over 250 drugs to markets. Through an uncompromising commitment to quality and service, a reputation for on-time performance, innovation at all levels, and delivery of services at reasonable costs, we have become trusted partners of many of the worlds leading pharmaceutical companies.